Chengdu Kanghua Biological Products (300841) — Strategic Asset Allocation Index
Chengdu Kanghua Biological Products (300841) has a Strategic Asset Allocation Index of 28.2% as of September 2023. Strategic assets (PP&E of CN¥954.01 Million plus long-term investments of CN¥-) total CN¥954.01 Million, measured against net assets of CN¥3.38 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Chengdu Kanghua Biological Products Strategic Asset Allocation Index (2017–2022)
This chart shows how Chengdu Kanghua Biological Products's Strategic Asset Allocation Index has evolved across 6 annual periods from 2017 to 2022. As of September 2023, the index stands at 28.2%, representing strategic assets of CN¥954.01 Million against net assets of CN¥3.38 Billion CNY. Explore 300841 cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Chengdu Kanghua Biological Products (2017–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Chengdu Kanghua Biological Products from 2017 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 300841 company net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 32.0% | CN¥985.45 Million | CN¥985.45 Million | CN¥- | CN¥3.08 Billion | ▲ +13.7 pp |
| 2021 | 18.3% | CN¥488.72 Million | CN¥488.72 Million | CN¥- | CN¥2.67 Billion | ▲ +8.1 pp |
| 2020 | 10.2% | CN¥202.13 Million | CN¥202.13 Million | CN¥- | CN¥1.97 Billion | ▼ -3.7 pp |
| 2019 | 13.9% | CN¥79.85 Million | CN¥79.85 Million | CN¥- | CN¥574.65 Million | ▼ -8.2 pp |
| 2018 | 22.1% | CN¥81.11 Million | CN¥81.11 Million | CN¥- | CN¥367.70 Million | ▼ -4.9 pp |
| 2017 | 27.0% | CN¥50.82 Million | CN¥50.82 Million | CN¥- | CN¥188.37 Million | — |